Earnings were $14.6 billion, or $5.07 a share, for the three months ended March 31. That compares with $13.4 billion a year earlier.

Uncertainty surrounding potential US tariffs is threatening to disrupt India's booming pharma deal market, according to ...

Dow, Nasdaq retreat more than 2% after global stocks surge in response to President Trump's partial tariff pause ...

President Trump’s latest round of tariffs went into full effect at midnight Wednesday, with higher import tax rates on dozens ...